A study published in Science Advances by researchers at Texas A&M University has identified a previously unknown biological pathway contributing to immune dysfunction in individuals with Down syndrome.
The research, led by Dr. Thomas Kent of the Institute of Biosciences and Technology and Dr. Larry Suva of the College of Veterinary Medicine and Biomedical Sciences, suggests that the SOD1 gene plays a larger role than previously recognized in driving excess hydrogen sulfide production.
Illnesses that are typically mild for most people can lead to serious complications, including pneumonia, hospitalization, or intensive care, for those with Down syndrome. Scientists have long known that excess hydrogen sulfide contributes to susceptibility to infections in this population. For years, the prevailing belief was that a chromosome 21 gene called CBS was largely responsible for this overproduction.
The new findings indicate that SOD1, which helps cells break down harmful oxygen molecules, acts through a non-canonical pathway associated with hydrogen sulfide production. This shift in understanding may help explain the chronic inflammation, increased infection susceptibility, and premature aging often associated with Down syndrome.
To reach these conclusions, Kent and Suva analyzed blood samples from 270 individuals with Down syndrome and 146 without the disease. They examined gene activity and immune-related proteins, finding that SOD1 was the most consistently elevated gene in individuals with the condition.
